FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Michael Cohen

Sort
E.g., 2013-05-25
E.g., 2013-05-25
Enter a comma separated list of user names.

The China Fund, Inc.(NYSE:CHN) confirmed the amount of distributions of $2.2742 per share. The capital gain portion of the distributions is comprised of long-term capital gains at $1.8996 per share. The net investment income portion of the distribution is $0.3746 per share.

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, reported that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii.

Proteonomix, Inc. (OTC.BB:PROT) reported that Proteonomix has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

RadioShack Corp. (NYSE: RSH) celebrated its 75th anniversary of listing on the New York Stock Exchange.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

___

Proteonomix, Inc. (PROT.OB)

PROT announced that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Proteonomix, Inc., (OTCBB:PROT.OB) has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

___

Proteonomix, Inc. (PROT.OB)

PROT announced that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Proteonomix, Inc. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, reported that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

Proteonomix, Inc., (OTCBB:PROT.OB) has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Pages

ADVERTISE WITH US